about
Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial.Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality.Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology databaseOutcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective AnalysisVolume-outcome relationships in pancreatoduodenectomy for cancerThe use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis.Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit.Minimally Invasive Versus Open Pancreatoduodenectomy: Systematic Review and Meta-analysis of Comparative Cohort and Registry Studies.Impact of a Nationwide Training Program in Minimally Invasive Distal Pancreatectomy (LAELAPS).Management of Severe Pancreatic Fistula After Pancreatoduodenectomy.Recent Advances in Pancreatic Cancer Surgery of Relevance to the Practicing Pathologist.Impact of a Nationwide Training Program in Minimally Invasive Distal Pancreatectomy (LAELAPS).Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey.Pancreatoduodenectomy with colon resection for cancer: A nationwide retrospective analysis.Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer.A nationwide comparison of laparoscopic and open distal pancreatectomy for benign and malignant disease.Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial.Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External Validation.Outcomes of a Multicenter Training Program in Laparoscopic Pancreatoduodenectomy (LAELAPS-2).Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.Current Strategies for Detection and Treatment of Recurrence of Pancreatic Ductal Adenocarcinoma After Resection: A Nationwide Survey.Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit.Diagnostic value of a pancreatic mass on computed tomography in patients undergoing pancreatoduodenectomy for presumed pancreatic cancer.
P50
Q30844620-C8EEB0E0-A7E5-4F62-8E98-34D782BF0715Q34246396-BD09855E-6891-4387-8DF2-182A80AAF737Q35925005-AAC537DD-2F59-49F3-AE9B-0F9032DC5895Q36480132-6F00C29A-89F1-4522-AB1C-DD61E32A287BQ36747425-DF227931-CC4C-489A-BD97-AC06FD9E3C7BQ37373088-A9926371-E2CD-4BEA-B05E-2D36A0C33555Q38654611-0DF5F470-9567-40D0-B4C7-F795F183584DQ38728359-B28782A2-E646-483C-B02C-9BBF1BE4575AQ38811672-2213FFBF-B754-4F7A-9AA8-1DB3C4D922FFQ38939598-B3E8D8DE-B5D5-4DD6-A5B2-57610657FAE0Q39031508-A15DD357-4419-4142-9994-F91B1EF96A3FQ39590507-EDEBC1A2-B0C6-4557-A499-CFEEA26A229FQ39990934-BFD3F3B6-7CBB-4484-AA52-A474B566B65AQ40810472-1D502520-D974-4A09-89F0-A24F84C2D1E0Q41262237-D4F6BC1E-528C-4E4E-ABCE-343D965CED27Q41561329-85BFE509-8FC3-4876-AEC5-4063EF0E647CQ47111447-457FA358-7FC0-484F-8D70-E4C6CD43CD29Q47151308-91C6059F-9DAB-435E-8985-C66F3F242260Q47193313-057B1DCC-66D7-4D66-B52E-1DEE62764295Q47861590-F87B0E4D-6928-4F09-993A-59D0973B02C0Q48194931-19D1E94D-D211-40F9-9A76-4CAF8C0D9381Q50118369-22162B00-5B20-41C2-BC70-152A40E78BE7Q52639894-C14DF5AF-59AA-4B07-8444-1AB75FF16C38Q53171644-41ECBFB4-15F4-438E-8B43-1745710654A0
P50
name
Dutch Pancreatic Cancer Group
@en
type
label
Dutch Pancreatic Cancer Group
@en
prefLabel
Dutch Pancreatic Cancer Group
@en